Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.

Literature DB >> 11709354

Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.

Abstract

Antimicrobial susceptibility testing of 192 group B streptococcal isolates from patients with invasive disease demonstrated that 31 (16%) were resistant to erythromycin and 17 (9%) were resistant to clindamycin. One isolate demonstrated high-level resistance to streptomycin, but none was highly resistant to gentamicin. Erythromycin and clindamycin are no longer reliable empirical alternatives to penicillin for the treatment and prevention of group B streptococcal infections.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2001 PMID： 11709354 PMCID： PMC90883 DOI： 10.1128/AAC.45.12.3623-3624.2001

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

9 in total

1. Change in antibiotic resistance of group B streptococcus: impact on intrapartum management.

Authors: W J Morales; S S Dickey; P Bornick; D V Lim
Journal: Am J Obstet Gynecol Date: 1999-08 Impact factor: 8.661

2. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators.

Authors: G J Tyrrell; L D Senzilet; J S Spika; D A Kertesz; M Alagaratnam; M Lovgren; J A Talbot
Journal: J Infect Dis Date: 2000-06-29 Impact factor: 5.226

3. Antibiotic susceptibility profile of group B streptococcus acquired vertically.

Authors: D J Rouse; W W Andrews; F Y Lin; C W Mott; J C Ware; J B Philips
Journal: Obstet Gynecol Date: 1998-12 Impact factor: 7.661

4. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis.

Authors: M Fernandez; M E Hickman; C J Baker
Journal: Antimicrob Agents Chemother Date: 1998-06 Impact factor: 5.191

5. High-level chromosomal gentamicin resistance in Streptococcus agalactiae (group B).

Authors: A Buu-Hoï; C Le Bouguenec; T Horaud
Journal: Antimicrob Agents Chemother Date: 1990-06 Impact factor: 5.191

6. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998.

Authors: F Y Lin; P H Azimi; L E Weisman; J B Philips; J Regan; P Clark; G G Rhoads; J Clemens; J Troendle; E Pratt; R A Brenner; V Gill
Journal: Clin Infect Dis Date: 2000-07-24 Impact factor: 9.079

7. High incidence of erythromycin-resistant streptococci in Taiwan.

Authors: J J Wu; K Y Lin; P R Hsueh; J W Liu; H I Pan; S M Sheu
Journal: Antimicrob Agents Chemother Date: 1997-04 Impact factor: 5.191

8. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin.

Authors: M D Pearlman; C L Pierson; R G Faix
Journal: Obstet Gynecol Date: 1998-08 Impact factor: 7.661

9. Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group.

Authors: K P Klugman; R Dagan
Journal: Antimicrob Agents Chemother Date: 1995-05 Impact factor: 5.191

9 in total

20 in total

1. Antimicrobial susceptibilities of group B streptococci in New Zealand.

Authors: Anja M Werno; Trevor P Anderson; David R Murdoch
Journal: Antimicrob Agents Chemother Date: 2003-08 Impact factor: 5.191

2. Use of the Vitek-1 and Vitek-2 systems for detection of constitutive and inducible macrolide resistance in group B streptococci.

Authors: Patrick Tang; Peter Ng; Ming Lum; Martin Skulnick; Glen W Small; Donald E Low; Alicia Sarabia; Tony Mazzulli; Katherine Wong; Andrew E Simor; Barbara M Willey
Journal: J Clin Microbiol Date: 2004-05 Impact factor: 5.948

3. Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital.

Authors: Ziya Cibali Acikgoz; Ebru Almayanlar; Sohret Gamberzade; Safiye Gocer
Journal: Antimicrob Agents Chemother Date: 2004-04 Impact factor: 5.191

4. Erythromycin and clindamycin resistance in group B streptococcal clinical isolates.

Authors: Scott E Gygax; Jessica A Schuyler; Lauren E Kimmel; Jason P Trama; Eli Mordechai; Martin E Adelson
Journal: Antimicrob Agents Chemother Date: 2006-05 Impact factor: 5.191

5. Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay.

Authors: Xianyu Zeng; Fanrong Kong; Hui Wang; Archie Darbar; Gwendolyn L Gilbert
Journal: Antimicrob Agents Chemother Date: 2006-01 Impact factor: 5.191

6. Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.

Authors: Noriyuki Nagano; Yukiko Nagano; Kouji Kimura; Kiyoko Tamai; Hideji Yanagisawa; Yoshichika Arakawa
Journal: Antimicrob Agents Chemother Date: 2008-09-22 Impact factor: 5.191